ONCOLOGY INSTITUTE INC/THE (TOI) Stock Analyst Earnings Estimates
NASDAQ:TOI - Nasdaq - US68236X1000 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 203M 8.27% | 252.5M 24.38% | 324.239M 28.41% | 418.81M 29.17% | 487.63M 16.43% | |
| EBITDA YoY % growth | -42.56M -747.81% | -67.59M -58.81% | -54.278M 19.70% | -18.079M 66.69% | 1.818M 110.06% | |
| EBIT YoY % growth | -45.9M -459.76% | -72M -56.86% | -60.151M 16.46% | -23.907M 60.26% | -3.862M 83.84% | |
| Operating Margin | -22.61% | -28.51% | -18.55% | -5.71% | -0.79% | |
| EPS YoY % growth | N/A | N/A | -0.69 -36.63% | -0.42 38.52% | -0.16 61.90% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.07 66.33% |
| Revenue Q2Q % growth | 110.24M 28.50% |
| EBITDA Q2Q % growth | -1.717M 81.76% |
| EBIT Q2Q % growth | -3.126M 79.55% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.18 5.26% | -0.06 | -0.12 | -197.03% |
| Q2 2024 Q2Q % growth | -0.17 10.53% | -0.10 | -0.07 | -68.32% |
| Q1 2024 Q2Q % growth | -0.22 -120.00% | -0.12 | -0.10 | -81.52% |
| Q4 2023 Q2Q % growth | -0.21 16.00% | -0.11 | -0.10 | -89.02% |
| Q3 2023 Q2Q % growth | -0.19 24.00% | -0.13 | -0.06 | -44.71% |
| Q2 2023 Q2Q % growth | -0.19 | -0.17 | -0.02 | -10.66% |
| Q4 2022 Q2Q % growth | -0.25 | -0.18 | -0.07 | -37.51% |
| Q3 2022 Q2Q % growth | -0.25 | -0.18 | -0.07 | -37.51% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 99.9M 21.78% | 108.62M | -8.72M | -8.03% |
| Q2 2024 Q2Q % growth | 98.578M 22.88% | 104.34M | -5.762M | -5.52% |
| Q1 2024 Q2Q % growth | 94.666M 24.25% | 96.117M | -1.451M | -1.51% |
| Q4 2023 Q2Q % growth | 85.788M 20.12% | 82.862M | 2.926M | 3.53% |
| Q3 2023 Q2Q % growth | 82.035M 26.25% | 75.411M | 6.624M | 8.78% |
| Q2 2023 Q2Q % growth | 80.224M 31.69% | 74.527M | 5.697M | 7.64% |
| Q1 2023 Q2Q % growth | 76.19M 38.13% | % | ||
| Q4 2022 Q2Q % growth | 71.42M 36.56% | 65.398M | 6.022M | 9.21% |
| Q3 2022 Q2Q % growth | 64.98M 24.32% | 69.64M | -4.66M | -6.69% |
| Q2 2022 Q2Q % growth | 60.92M 22.23% | % | ||
| Q1 2022 Q2Q % growth | 55.16M 13.54% | % | ||
| Q4 2021 Q2Q % growth | 52.3M 6.80% | % | ||
| Q3 2021 Q2Q % growth | 52.27M 10.62% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | 0% | 0% | 0% | 0% |